Loading...
Market
Will AMD and Absci announce a new AI drug discovery breakthrough by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Scientific publications, press releases from Absci or AMD, or credible news reports
Story
AMD Invests $20 Million in Absci via PIPE to Enhance AI Drug Discovery with AMD GPUs
Jan 8, 2025, 01:19 PM
Advanced Micro Devices Inc. (AMD) has announced a strategic investment of $20 million in Absci Corporation (ABSI), a company focused on AI-driven drug discovery. The investment, structured as a private investment in public equity (PIPE), aims to enhance AMD's presence in the healthcare sector by leveraging its artificial intelligence chips. This collaboration will see Absci deploying AMD's high-performance compute and software solutions to advance the development of next-generation antibody therapeutics. The partnership is part of AMD's broader strategy to expand into life sciences and other industries, positioning its graphics processing units (GPUs) for specialized applications. Absci, based in Washington state, currently utilizes over 470 AI chips, predominantly from Nvidia, but plans to increase its use of AMD's GPUs following this investment.
View original story
Similar markets
Fully adopted across all pipelines • 25%
Not adopted • 25%
Minimal adoption • 25%
Partially adopted in some pipelines • 25%
Stock price changes by less than 10% • 25%
Stock price decreases • 25%
Stock price increases by more than 20% • 25%
Stock price increases by 10-20% • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
OpenAI • 25%
Neither • 25%
Both • 25%
Anthropic • 25%